CS Disco(LAW)

Search documents
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALAR
GlobeNewswire News Room· 2025-02-20 20:11
Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Alarum Technologies Ltd. securities, alleging that the company made false and misleading statements regarding its business performance during the specified Class Period from March 14, 2024, to August 26, 2024 [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Alarum was less effective in retaining and expanding customer engagements than it had represented, which impaired its ability to generate consistent revenue growth [5]. - The lawsuit alleges that Alarum's business and financial prospects were overstated, leading to materially false and misleading public statements [5]. - Investors are encouraged to join the class action without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the Alarum class action by visiting the provided link or contacting Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must move the Court by April 15, 2025, to represent other class members in directing the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and recovering hundreds of millions for investors [4]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013, securing over $438 million for investors in 2019 alone [4].
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALAR
GlobeNewswire News Room· 2025-02-18 00:12
Core Viewpoint - A class action lawsuit has been filed against Alarum Technologies Ltd. for alleged misleading statements regarding its business performance during the specified Class Period from March 14, 2024, to August 26, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Alarum was less effective in retaining and expanding customer engagements than represented, which impaired its ability to generate consistent revenue growth [5]. - It is alleged that Alarum's business and financial prospects were overstated, leading to materially false and misleading public statements [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and has a strong track record, including recovering over $438 million for investors in 2019 [4]. - Investors are advised to select qualified counsel with a proven history in leadership roles within class action lawsuits [4]. - A lead plaintiff must be appointed by April 15, 2025, to represent the interests of the class members in the litigation [1][3].
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
GlobeNewswire News Room· 2025-02-14 20:43
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., February 14, 2025. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025. SO WHAT: If you purchased M ...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
GlobeNewswire News Room· 2025-02-14 15:40
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Crocs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CROX
GlobeNewswire News Room· 2025-02-12 20:34
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Crocs, Inc. (NASDAQ: CROX) between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”), of the important March 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Crocs common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT ...
ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
GlobeNewswire News Room· 2025-02-09 04:34
NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NXT
GlobeNewswire News Room· 2025-02-07 02:41
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nextracker Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Nextracker common stock between February 1, 2024, and August 1, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 25, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Nextracker - The lawsuit alleges that Nextracker made false and misleading statements regarding the impact of project delays on its business and financial results [5]. - Specific claims include that permitting and interconnection delays severely impaired Nextracker's ability to convert backlog into revenue, and that the company could not offset negative impacts from these delays as previously claimed [5]. - The lawsuit asserts that Nextracker lacked the competitive advantages it claimed, leading to a lack of reasonable basis for its positive statements about its business prospects [5].
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
GlobeNewswire News Room· 2025-02-05 20:11
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased ESSA Pharma Inc. securities during the Class ...
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grocery Outlet Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GO
GlobeNewswire News Room· 2025-02-02 13:12
Core Viewpoint - A class action lawsuit has been filed against Grocery Outlet Holding Corp. for allegedly providing misleading information regarding its transition to new systems, which may have impacted its profitability during the Class Period from November 7, 2023, to May 7, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Grocery Outlet made overwhelmingly positive statements while concealing material adverse facts about its operational transition, leading to investor damages when the truth was revealed [5]. - Investors who purchased Grocery Outlet securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is encouraging investors to select qualified counsel with a proven track record [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6]. Group 3: Class Certification - No class has been certified yet, meaning investors are not represented by counsel unless they retain one [7]. - Investors have the option to remain absent class members and are not required to serve as lead plaintiffs to share in any potential recovery [7].
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO
GlobeNewswire News Room· 2025-02-02 00:30
NEW YORK, Feb. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased Novo Nordisk securities during the Class Per ...